Answers are grounded in this paper and cite their sources.
Dosimetric comparison of Taichi Pro and Halcyon shows enhanced dose escalation in prostate cancer, indicating better treatment outcomes.
Utilizing the steep dose gradient characteristic of the RGS, the Taichi Pro dual-modality system effectively achieved target dose escalation while simultaneously improving sparing of adjacent OARs. This approach holds the potential for enhancing patient treatment outcomes and quality of life.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: